MPM BioVentures 2018 GP LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 106,219 shares at $27.96 ($2.9M) on 2021-09-23, disclosed to the SEC on 2021-09-27.
Scheduled sale ($2.9M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.96 | 36,213 | $1.0M | 34.3% |
| 2 | $27.96 | 36,213 | $1.0M | 34.3% |
| 3 | $28.38 | 717 | $20K | 0.7% |
| 4 | $27.81 | 4,913 | $137K | 4.6% |
| 5 | $27.81 | 4,913 | $137K | 4.6% |
| 6 | $27.09 | 11,625 |
| $315K |
| 10.7% |
| 7 | $27.09 | 11,625 | $315K | 10.7% |
| Total | $27.76 avg | 106,219 | $2.9M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $12.5M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |
| ITOS | SELL | 2021-10-14 | $2.3M | — | Filing → |